back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-04-06 10:48 Tx date 2022-03-31 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Genesis Master Fund, L.P. (Control or Direction)
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-56,280
-469,000 vol $0.12 each |
5,711,000 | |
| Filed 2022-04-06 10:48 Tx date 2022-03-30 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Genesis Master Fund, L.P. (Control or Direction)
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-20,280
-156,000 vol $0.13 each |
6,180,000 | |
| Filed 2022-04-06 10:47 Tx date 2022-03-29 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Genesis Master Fund, L.P. (Control or Direction)
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-37,245
-286,500 vol $0.13 each |
6,336,000 | |
| Filed 2022-04-06 10:47 Tx date 2022-03-28 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Genesis Master Fund, L.P. (Control or Direction)
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-20,865
-160,500 vol $0.13 each |
6,622,500 | |
| Filed 2022-04-06 10:46 Tx date 2022-03-25 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Genesis Master Fund, L.P. (Control or Direction)
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-13,200
-110,000 vol $0.12 each |
6,783,000 | |
| Filed 2022-04-06 10:45 Tx date 2022-03-24 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Genesis Master Fund, L.P. (Control or Direction)
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-4,355
-33,500 vol $0.13 each |
6,893,000 | |
| Filed 2022-04-06 10:45 Tx date 2022-03-23 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Genesis Master Fund, L.P. (Control or Direction)
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-13,000
-100,000 vol $0.13 each |
6,926,500 | |
| Filed 2022-04-06 10:44 Tx date 2022-03-23 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Genesis Master Fund, L.P. (Control or Direction)
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-280.00
-2,000 vol $0.14 each |
7,026,500 | |
| Filed 2022-04-06 10:44 Tx date 2022-03-22 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Genesis Master Fund, L.P. (Control or Direction)
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-9,600
-64,000 vol $0.15 each |
7,028,500 | |
| Filed 2022-04-06 10:43 Tx date 2022-03-21 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Genesis Master Fund, L.P. (Control or Direction)
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-1,050
-7,000 vol $0.15 each |
7,092,500 | |
| Filed 2022-04-06 10:42 Tx date 2022-03-18 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Genesis Master Fund, L.P. (Control or Direction)
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-1,840
-11,500 vol $0.16 each |
7,099,500 | |
| Filed 2022-04-06 10:41 Tx date 2022-03-16 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Genesis Master Fund, L.P. (Control or Direction)
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-5,440
-32,000 vol $0.17 each |
7,111,000 | |
| Filed 2022-02-08 14:26 Tx date 2021-02-19 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Genesis Master Fund, L.P. (Control or Direction)
|
Subordinate Voting Shares
00 - Opening Balance-Initial SEDI Report
|
7,143,000 | ||
| Filed 2020-11-17 12:29 Tx date 2020-03-03 |
$HLS
HLS Therapeutics Inc. |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-762,356.30
-47,030 vol $16.21 each |
605,598 | |
| Filed 2020-11-17 12:28 Tx date 2020-02-27 |
$HLS
HLS Therapeutics Inc. |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,658.95
-235 vol $15.57 each |
652,628 | |
| Filed 2020-11-17 12:28 Tx date 2020-03-03 |
$HLS
HLS Therapeutics Inc. |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,286,906.80
-141,080 vol $16.21 each |
1,816,803 | |
| Filed 2020-11-17 12:27 Tx date 2020-02-27 |
$HLS
HLS Therapeutics Inc. |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-10,992.42
-706 vol $15.57 each |
1,957,883 | |
| Filed 2020-11-17 12:26 Tx date 2020-03-03 |
$HLS
HLS Therapeutics Inc. |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-192,736.90
-11,890 vol $16.21 each |
51,214 | |
| Filed 2020-11-17 12:24 Tx date 2020-02-27 |
$HLS
HLS Therapeutics Inc. |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-918.63
-59 vol $15.57 each |
63,104 | |
| Filed 2020-11-17 12:21 Tx date 2020-08-11 |
$HLS
HLS Therapeutics Inc. |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Warrants
55 - Expiration of warrants
|
-63,193 vol |
135,836 | |
| Filed 2020-11-17 12:21 Tx date 2020-08-11 |
$HLS
HLS Therapeutics Inc. |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Control or Direction)
|
Warrants
55 - Expiration of warrants
|
-189,578 vol |
407,507 | |
| Filed 2020-11-17 12:20 Tx date 2020-08-11 |
$HLS
HLS Therapeutics Inc. |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Warrants
55 - Expiration of warrants
|
-63,193 vol |
135,836 | |
| Filed 2020-06-15 09:32 Tx date 2020-06-09 |
$BLU
BELLUS Health Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments VII, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,522,468
-148,100 vol $10.28 each |
4,795,316 | |
| Filed 2020-06-15 09:31 Tx date 2020-06-10 |
$BLU
BELLUS Health Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-366,184
-36,400 vol $10.06 each |
1,182,416 | |
| Filed 2020-06-15 09:26 Tx date 2020-06-10 |
$BLU
BELLUS Health Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-366,184
-36,400 vol $10.06 each |
||
| Filed 2020-06-15 09:25 Tx date 2020-06-10 |
$BLU
BELLUS Health Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,009,000
-700,900 vol $10.00 each |
1,218,816 | |
| Filed 2020-06-15 09:24 Tx date 2020-06-10 |
$BLU
BELLUS Health Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments VII, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,991,000
-799,100 vol $10.00 each |
3,954,800 | |
| Filed 2020-06-15 09:23 Tx date 2020-06-10 |
$BLU
BELLUS Health Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments VII, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-416,644.96
-41,416 vol $10.06 each |
4,753,900 | |
| Filed 2020-06-15 09:22 Tx date 2020-06-09 |
$BLU
BELLUS Health Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,672,556
-162,700 vol $10.28 each |
1,919,716 | |
| Filed 2020-06-15 09:21 Tx date 2020-06-09 |
$BLU
BELLUS Health Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments VII, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,522,468
-148,100 vol $10.28 each |
||
| Filed 2020-01-07 17:15 Tx date 2020-01-02 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-568.728
-63,192 vol $0.009 each |
199,029 | |
| Filed 2020-01-07 17:13 Tx date 2020-01-02 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$568.47
+63,163 vol $0.009 each |
652,863 | |
| Filed 2020-01-07 17:12 Tx date 2020-01-02 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-1,706.184
-189,576 vol $0.009 each |
597,085 | |
| Filed 2020-01-07 17:10 Tx date 2020-01-02 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$1,705
+189,489 vol $0.009 each |
1,958,589 | |
| Filed 2020-01-07 17:07 Tx date 2020-01-02 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-568.728
-63,192 vol $0.009 each |
199,029 | |
| Filed 2020-01-07 17:06 Tx date 2020-01-02 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$568.47
+63,163 vol $0.009 each |
63,163 | |
| Filed 2019-12-20 16:12 Tx date 2019-12-17 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,191,400
-220,600 vol $19.00 each |
2,138,210 | |
| Filed 2019-12-20 16:11 Tx date 2019-12-18 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,105,367.50
-369,110 vol $19.25 each |
1,769,100 | |
| Filed 2019-12-20 16:10 Tx date 2019-12-18 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,369,213
-123,076 vol $19.25 each |
589,700 | |
| Filed 2019-12-20 16:10 Tx date 2019-12-18 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,102,062.50
-57,250 vol $19.25 each |
0 | |
| Filed 2019-12-20 16:09 Tx date 2019-12-17 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,396,500
-73,500 vol $19.00 each |
712,776 | |
| Filed 2019-12-20 16:08 Tx date 2019-12-17 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-112,100
-5,900 vol $19.00 each |
57,250 | |
| Filed 2019-12-20 16:07 Tx date 2019-12-17 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,522.40
-80 vol $19.03 each |
2,358,810 | |
| Filed 2019-12-20 16:06 Tx date 2019-12-17 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-380.60
-20 vol $19.03 each |
786,276 | |
| Filed 2019-11-20 17:54 Tx date 2019-11-15 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$568.35
+63,150 vol $0.009 each |
786,296 | |
| Filed 2019-11-20 17:53 Tx date 2019-11-15 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-568.728
-63,192 vol $0.009 each |
262,221 | |
| Filed 2019-11-20 17:51 Tx date 2019-11-15 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$1,705
+189,450 vol $0.009 each |
2,358,890 | |
| Filed 2019-11-20 17:50 Tx date 2019-11-15 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-1,706.184
-189,576 vol $0.009 each |
786,661 | |
| Filed 2019-11-20 17:47 Tx date 2019-11-15 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$568.35
+63,150 vol $0.009 each |
63,150 | |
| Filed 2019-11-20 17:46 Tx date 2019-11-15 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-568.728
-63,192 vol $0.009 each |
262,221 | |
| Filed 2019-11-20 17:45 Tx date 2019-11-15 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-568.728
-63,192 vol $0.009 each |
||
| Filed 2019-11-20 17:44 Tx date 2019-11-15 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-568.728
-63,192 vol $0.009 each |
||
| Filed 2019-11-20 17:43 Tx date 2019-11-15 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$568.35
+63,150 vol $0.009 each |
||
| Filed 2019-11-20 17:43 Tx date 2019-11-15 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$568.35
+63,150 vol $0.009 each |
||
| Filed 2019-11-20 17:41 Tx date 2019-11-15 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$568.35
+63,150 vol $0.009 each |
||
| Filed 2019-11-20 17:37 Tx date 2019-11-15 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-568.728
-63,192 vol $0.009 each |
||
| Filed 2019-09-06 16:32 Tx date 2019-09-05 |
$BLU
BELLUS Health Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments VII, LP (Control or Direction)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$1,988,000
+280,000 vol $7.10 each |
4,943,416 | |
| Filed 2019-09-06 16:32 Tx date 2019-08-15 |
$BLU
BELLUS Health Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments VII, LP (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-12,124,884 vol |
4,663,416 | |
| Filed 2019-09-06 16:27 Tx date 2019-09-05 |
$BLU
BELLUS Health Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$2,982,000
+420,000 vol $7.10 each |
2,082,416 | |
| Filed 2019-09-06 16:26 Tx date 2019-08-15 |
$BLU
BELLUS Health Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-4,322,284 vol |
1,662,416 | |
| Filed 2019-09-06 16:21 Tx date 2019-09-05 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,087,457.50
-673,145 vol $13.50 each |
0 | |
| Filed 2019-08-21 18:28 Tx date 2019-08-16 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-700,000
-50,000 vol $14.00 each |
673,145 | |
| Filed 2019-08-21 18:27 Tx date 2019-04-03 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$1,894
+189,440 vol $0.01 each |
2,169,440 | |
| Filed 2019-08-21 18:26 Tx date 2019-04-03 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$631.46
+63,146 vol $0.01 each |
723,146 | |
| Filed 2019-08-21 18:24 Tx date 2019-04-03 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$631.46
+63,146 vol $0.01 each |
723,145 | |
| Filed 2019-08-21 18:23 Tx date 2019-04-03 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-1,895.76
-189,576 vol $0.01 each |
976,237 | |
| Filed 2019-08-21 18:19 Tx date 2019-04-03 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-631.92
-63,192 vol $0.01 each |
325,413 | |
| Filed 2019-08-21 18:18 Tx date 2019-04-03 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-631.92
-63,192 vol $0.01 each |
325,413 | |
| Filed 2019-08-21 18:17 Tx date 2019-04-03 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-631.92
-63,192 vol $0.01 each |
||
| Filed 2019-08-21 18:17 Tx date 2019-08-03 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-631.92
-63,192 vol $0.01 each |
||
| Filed 2019-08-21 18:16 Tx date 2019-04-03 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-631.92
-63,192 vol $0.01 each |
||
| Filed 2019-08-21 18:15 Tx date 2019-08-03 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-631.92
-63,192 vol $0.01 each |
||
| Filed 2019-08-21 18:14 Tx date 2019-04-03 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-631.92
-63,192 vol $0.01 each |
||
| Filed 2019-08-21 18:13 Tx date 2019-08-03 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-631.92
-63,192 vol $0.01 each |
||
| Filed 2019-05-12 14:00 Tx date 2019-05-10 |
$BLU
BELLUS Health Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments VII, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$284,000
+200,000 vol $1.42 each |
16,788,300 | |
| Filed 2019-05-12 13:59 Tx date 2019-05-09 |
$BLU
BELLUS Health Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments VII, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$200,513
+145,300 vol $1.38 each |
16,588,300 | |
| Filed 2019-05-12 13:59 Tx date 2019-05-08 |
$BLU
BELLUS Health Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments VII, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$435,780
+322,800 vol $1.35 each |
16,443,000 | |
| Filed 2019-05-12 13:58 Tx date 2019-05-07 |
$BLU
BELLUS Health Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments VII, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$977,358
+794,600 vol $1.23 each |
16,120,200 | |
| Filed 2019-05-12 13:57 Tx date 2019-05-10 |
$BLU
BELLUS Health Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments VII, LP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$284,000
+200,000 vol $1.42 each |
||
| Filed 2019-05-12 13:57 Tx date 2019-05-09 |
$BLU
BELLUS Health Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments VII, LP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$200,513
+145,300 vol $1.38 each |
||
| Filed 2019-05-12 13:57 Tx date 2019-05-08 |
$BLU
BELLUS Health Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments VII, LP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$435,780
+322,800 vol $1.35 each |
||
| Filed 2019-05-12 13:56 Tx date 2019-05-07 |
$BLU
BELLUS Health Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments VII, LP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$977,358
+794,600 vol $1.23 each |
||
| Filed 2019-05-12 13:56 Tx date 2019-05-10 |
$BLU
BELLUS Health Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments VII, LP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$284,000
+200,000 vol $1.42 each |
||
| Filed 2019-05-12 13:55 Tx date 2019-05-09 |
$BLU
BELLUS Health Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments VII, LP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$200,513
+145,300 vol $1.38 each |
||
| Filed 2019-05-12 13:55 Tx date 2019-05-08 |
$BLU
BELLUS Health Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments VII, LP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$435,780
+322,800 vol $1.35 each |
||
| Filed 2019-05-12 13:54 Tx date 2019-05-07 |
$BLU
BELLUS Health Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments VII, LP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$977,358
+794,600 vol $1.23 each |
||
| Filed 2018-12-20 Tx date 2018-12-18 |
$BLU
BELLUS Health Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments VII, LP (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,625,800 | ||
| Filed 2018-12-20 Tx date 2018-12-18 |
$BLU
BELLUS Health Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments VII, LP (Control or Direction)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$12,064,810
+12,699,800 vol $0.95 each |
15,325,600 | |
| Filed 2018-12-20 Tx date 2018-12-18 |
$BLU
BELLUS Health Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,784,700 | ||
| Filed 2018-12-20 Tx date 2018-12-18 |
$BLU
BELLUS Health Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$3,990,000
+4,200,000 vol $0.95 each |
5,984,700 | |
| Filed 2018-03-16 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-16 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-16 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-16 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+659,999 vol |
659,999 | |
| Filed 2018-03-16 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Control or Direction)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+1,980,000 vol |
1,980,000 | |
| Filed 2018-03-16 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-16 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+660,000 vol |
660,000 | |
| Filed 2018-03-16 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-16 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Partners Master Fund Limited (Control or Direction)
|
Warrants
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+388,605 vol |
388,605 | |
| Filed 2018-03-16 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-16 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Royalty Opportunities II, LP (Control or Direction)
|
Warrants
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+1,165,813 vol |
1,165,813 | |
| Filed 2018-03-16 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Royalty Opportunities S.àr.l. (Control or Direction)
|
Warrants
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+388,605 vol |
388,605 | |
| Filed 2017-08-22 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments IV, LP (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
10,425,225 | ||
| Filed 2016-09-09 Tx date 2016-09-06 |
$CTH
Cynapsus Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments V, LP (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-24,657,918.75
-620,325 vol $39.75 each |
1,000,000 | |
| Filed 2016-07-12 Tx date 2016-07-06 |
$CTH
Cynapsus Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments V, LP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-07-12 Tx date 2016-07-06 |
$CTH
Cynapsus Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments V, LP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,620,325 | ||
| Filed 2016-07-12 Tx date 2016-07-06 |
$CTH
Cynapsus Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments V, LP (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-07-12 Tx date 2016-07-06 |
$CTH
Cynapsus Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments V, LP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-07-12 Tx date 2016-07-06 |
$CTH
Cynapsus Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments V, LP (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-07-12 Tx date 2016-07-06 |
$CTH
Cynapsus Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments V, LP (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
316,154 | ||
| Filed 2016-07-12 Tx date 2016-07-06 |
$CTH
Cynapsus Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments V, LP (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-07-12 Tx date 2016-07-06 |
$CTH
Cynapsus Therapeutics Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments V, LP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|